James Mullen
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
James C. Mullen est un homme d'affaires qui a été à la tête de 11 entreprises différentes et qui occupe actuellement le poste de président non exécutif chez Percivia LLC, de président, président et directeur général d'Editas Medicine, Inc. et de directeur général de DPx Holdings BV. Il est également membre du conseil d'administration de Thermo Fisher Scientific, Inc. et de The Rivers School Corp. et membre du Biomedical Sciences Careers Program, Inc. Dans le passé, James C. Mullen a occupé les postes de président exécutif chez Vicarius Pharma AG, de président, de directeur général et de directeur chez Biogen, Inc. directeur chez Biogen Idec, Inc. (Caroline du Nord) et président de Biogen Idec New Ventures, Inc. (toutes deux filiales de Biogen, Inc.), président de Torque Therapeutics, Inc. et directeur général et directeur non indépendant de Patheon, Inc. et directeur général et directeur exécutif de Patheon NV, directeur de GlaxoSmithKline LLC et président de la Biotechnology Innovation Organization. Il est titulaire d'un MBA de l'université Villanova et d'un diplôme de premier cycle du Rensselaer Polytechnic Institute.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2026 | 3 393 ( 0 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Biomedical Sciences Careers Program, Inc. | Corporate Officer/Principal | - |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Président | - |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Directeur/Membre du Conseil | 20/05/2026 |
| EDITAS MEDICINE, INC. | Directeur Général | 01/06/2022 |
| INSULET CORPORATION | Directeur/Membre du Conseil | 28/01/2019 |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Président | 25/01/2019 |
| PATHEON N.V. | Directeur Général | 29/08/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 19 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insulet Corp.
Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Commercial Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Retail Trade |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national